Xerox Reveals Suite of Production Print Innovations to Address Industry Demand
Xerox (NYSE: XRX) announced a suite of production print innovations including new presses, technology enhancements for existing printers as well as artificial intelligence and automation features that aid speed and productivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118006025/en/
Innovation champion, Bindi Karia hosted the Xerox Production Innovation Reveal (Photo: Business Wire)
At a virtual event attended by partners and clients around the world, Xerox unveiled the following innovations:
- A Color Accelerator module for Baltoro, expanding inkjetapplications and adding ink-saving automation
- Addition of fluorescent pink to the Iridesse Production Press, enhancing its metallics, white and clear color palette
- Three new printers capable of higher volumes, more media and extended color options in the VersaLink and Versant family
- Two Xerox Nuvera print speed upgrades that best competition
- AI-enabled media manager software that enables high-quality images with minimal set-up and staff time
- Automated workflow updates to seamlessly print embellishments with FreeFlow Core 6.0
As the leader in the production color market, Xerox is committed to helping customers expand their business, enhance productivity with new technology and protect their existing investments with new tools and features.
Digital print enhancements increase profitability, delivering higher margins and allowing print customers to expand into new areas. According to Keypoint Intelligence, digital print enhancement is expected to generate $25 billion a year and can increase a printers’ profit by 50 to 400 percent. By making it easier, customizable and faster to produce these pages, Xerox technology provides multiple entry options for customers to expand their business and increase profit.
“Print enhancement is the fastest-growing segment in print and Xerox offers the broadest set of solutions to help clients expand their business here,” said Tracey Koziol, senior vice president of Global Offerings, Xerox. “The new technology and features we are launching expand the capabilities and profit potential of existing devices while introducing new presses that respond to demand for higher volume and extended media and color palettes. There’s a reason Xerox remains top in the production print market.”
Xerox Color Accelerator for Baltoro
The Xerox Baltoro™ High Fusion Inkjet Press platform, No. 1 in the B3 cut-sheet inkjet market, now has a field-upgradable module that expands its range. The Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press enables increased print quality, expanded media options and automation to make inkjet printing viable for lucrative applications such as direct mail, postcards and catalogs. With intelligent automation, Baltoro uses 50% less ink than competitor presses to purge inkjet heads, increasing uptime and productivity while delivering consistent, reliable quality.
Introduced last year, Baltoro is redefining the inkjet market. At a fraction of the size, weight and power consumption of competitor presses, Baltoro offers a lower total cost of ownership (TCO) while being the only scalable, customizable platform in its class.
Fluorescent Pink for Iridesse
Xerox has the broadest color capability and Beyond CMYK offerings across any portfolio. No one offers the range of colors, embellishments, mixed metallics, extended gamut, media options and single-pass digital enhancement technology as Xerox.
The Xerox Iridesse® Production Pressis adding fluorescent pink specialty dry ink option to its existing Beyond CMYK palette of gold, silver, white and clear. These embellishments allow print providers to differentiate and offer their clients eye-popping designs and enhancements.
New VersaLink Graphic Arts Printer
The newest addition to our VersaLink family is the Xerox VersaLink® C8000W, the most affordable entry point into the embellishment market. Using white toner as a base on dark and colored stocks, its cyan, magenta and yellow toners make images pop for applications such as menus, envelopes, window clings, decals and labels. A small footprint device, the C8000W offers clarity and quality that stands out over the typical four-color print.
Two New Versants
Xerox is expanding its Versant family of presses with two new machines that support wider media options and add automation features that reduce staffing needs and set-up time.
The Xerox Versant® 280 Press, a mid-production press, provides added value with thicker stock media options (400 GSM) for applications such as business cards. With the All Stocks at Rated Speed (ASRS) option, the Versant 280 is faster than any competitor in printing heavy stocks. Customers can print a million specialty colors using an Adaptive CMYK+ kit that leverages white, gold, silver, clear and fluorescents, unique to Xerox in this class of products.
The Xerox Versant 4100 Press,handles higher volumes and heavier production loads than the Versant 280, bringing more jobs in-house by reducing set-up time and printing on more media types than any competitor press. The 4100 also handles thicker paper stocks, up to 400 GSM. Automated stock management saves time and reduces human error.
Faster Xerox Nuveras
The Xerox Nuvera® family is built for high production environments with our customers making more than 35 billion prints last year. The Xerox Nuvera 157 MX Production System and Xerox Nuvera MX Perfecting Production System monochrome production presses have upgraded the magnetic ink character recognition (MICR) print speeds to exceed any competitive press. MICR, the line of numbers that allows certain computers to read and process information, is key for processing bank, payroll and government checks with tested and trusted Xerox Nuvera security.
AI-enabled media manager software. PredictPrint Media Manager Software is included with the new Versant 4100 and can be added to Iridesse. By using artificial intelligence, the software automatically identifies the media being used and provides the correct press settings. Users simply scan a barcode, place the paper in a tray, and use the set-up wizard to walk through optimizing the system for that application.
FreeFlow® Core 6.0 automates the process of preparing a file to print and now includes the application of Beyond CMYK enhancements. FreeFlow Core uses pre-built workflows to seamlessly apply embellishments such as gold, silver, white, clear and fluorescents without changing the source file.
“These new products and features represent the sweet spot of technology, where end-to-end solutions support our customers need to differentiate and expand their businesses in any economic environment,” said Marybeth Gilbert, vice president and general manager, Production Business, Xerox. “Our customers know they can count on Xerox innovation in response to their business needs.”
- Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press - Current Baltoro customers will be able to order Color Accelerator beginning in 2021. New Baltoro customers will be able to place orders for Color Accelerator starting December 15 with installs expected to begin in Q1 2021.
- The VersaLink C8000W is available immediately worldwide.
- The Xerox Nuvera 157 MX Production System and Xerox Nuvera 314 MX Perfecting Production System - order taking and availability December 1, 2020.
- The Xerox Versant 280 is available now based upon channel and geography.
- The Xerox Versant 4100 with PredictPrint Media Manager Software is available now based upon channel and geography.
- Iridesse pink specialty dry ink option and the PredictPrint Media Manager Software option are available for order taking December 1, 2020 and availability beginning March 1, 2021.
- The XLS Automatic Feeding Kit option for Iridesse is available immediately worldwide.
Xerox Holdings Corporation (NYSE: XRX) makes every day work better. We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. Learn how that innovation continues at xerox.com.
Note: To receive RSS news feeds, visit https://www.news.xerox.com. For open commentary, industry perspectives and views, visit http://twitter.com/xerox, http://www.facebook.com/XeroxCorp, https://www.instagram.com/xerox/, http://www.linkedin.com/company/xerox, http://www.youtube.com/XeroxCorp.
Xerox®, Baltoro™, FreeFlow®, Iridesse®, VersaLink®, Versant® and Xerox Nuvera® are trademarks of Xerox in the United States and/or other countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kyowa Kirin Provides Update on Application for Marketing Authorisation of Istradefylline in Europe for the Treatment of ‘OFF’ Episodes in People Living with Parkinson’s23.7.2021 16:05:00 CEST | Press release
Kyowa Kirin Co., Ltd. (TSE:4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion for istradefylline as an add-on treatment to levodopa (L-Dopa) based regimens in adults living with Parkinson’s, experiencing end-of-dose motor fluctuations. Kyowa Kirin International remain committed to istradefylline and people living with Parkinson’s and are currently reviewing the options available, which may include re-examination. “We are disappointed by the CHMP opinion. However, we remain confident in the benefit-risk profile of istradefylline and are committed to making a difference to the lives of people living with Parkinson’s, an area which has had few innovative therapies for decades,” said Abdul Mullick, President of Kyowa Kirin International. “There are currently few new treatment options available to manage end-of-dose motor fluctuations in Parkinson
ForumPay Teams Up with Bambora to Conquer the Crypto-to-Fiat Payments Market23.7.2021 15:16:00 CEST | Press release
ForumPay, an international cryptocurrency-to-fiat payment service provider, has established a partnership with the global payments provider Bambora, a Worldline brand, to bring seamless crypto payment solutions to merchants and online shoppers. The partnership will cater to a large global audience and offer expanded payment options for both shoppers and merchants. ForumPay continues its march to dominate the growing crypto payments ecosystem for merchants around the world. “ForumPay provides merchants with a seamless, secure and instant processing solution to accept payments from the more than 54 million active crypto wallet users around the world. By providing a payments service for processing crypto into fiat that functions as naturally as card payments, ForumPay enables merchants with a familiar feeling payments alternative that also gives them a competitive advantage by tapping into the fastest growing consumer base on the planet.” says Joshua Tate, CEO of ForumPay. “We are very ex
Wipro Recognized as 2021 Microsoft Modernizing Applications Partner of the Year23.7.2021 14:54:00 CEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has won the 2021 Microsoft Partner of the Year Award in the Modernizing Applications category. In addition, Wipro was also named as a category finalist in the 2021 AI Partner of the Year category, solidifying its reputation as an innovator in multiple sectors. This recognition highlights Wipro’s deep expertise and ability to go above and beyond for its customers, powered by an established partnership with Microsoft. Even when working with complex customer environments, spanning across hundreds of servers with different applications of different versions, Wipro was able to help customers meet their business needs and leverage the power of public cloud in an efficient way. “Global enterprises have embraced modernization at an unprecedented scale and pace, and the demands of the past year show no sign of easing. We are honor
Merck Announces Appointment of Head of China & International for Healthcare23.7.2021 13:45:00 CEST | Press release
Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow will report to Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. She will serve as a member of the Healthcare Executive Committee, and be based in Shanghai, China. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210723005186/en/ Merck Announces Appointment of Head of China & International for Healthcare (Photo: Business Wire) “Hong’s international experience and strong track record of bringing innovative medicines to patients in need across both developed and emerging markets, most nota
H.I.G. WhiteHorse Refinances Grupo Recoletas23.7.2021 13:03:00 CEST | Press release
H.I.G. WhiteHorse, a credit affiliate of global investment firm H.I.G. Capital ("H.I.G.") is pleased to announce that it has arranged a refinancing package for Grupo Hospitalario Recoletas (“Recoletas”), which includes a significant growth capital component. Recoletas is a family-owned Spanish private hospital operator headquartered in Valladolid, Spain, with a leading position in the Castilla y Leon Spanish inland region. It operates 8 hospitals with c. 540 beds and 13 medical centres across 7 regions. H.I.G. WhiteHorse has committed €110 million in unitranche loans to refinance the borrower's existing indebtedness and provide additional capital to finance growth, supporting the Company’s expansion. Recoletas is currently developing ambitious projects to expand its healthcare services provided through hospitals and medical centers, as well as diagnostic imaging centers and radiotherapy units. Amando J. Rodríguez, President and CEO of Grupo Hospitalario Recoletas, said: “We are very ha
Schlumberger Announces Second-Quarter 2021 Results23.7.2021 12:50:00 CEST | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the second-quarter 2021. Second-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2021Mar. 31, 2021Jun. 30, 2020SequentialYear-on-yearRevenue* $5,634 $5,223 $5,356 8% 5% Income (loss) before taxes - GAAP basis $542 $386 $(3,627) 40% n/m Net income (loss) - GAAP basis $431 $299 $(3,434) 44% n/m Diluted EPS (loss per share) - GAAP basis $0.30 $0.21 $(2.47) 43% n/m Adjusted EBITDA** $1,198 $1,049 $838 14% 43% Adjusted EBITDA margin** 21.3% 20.1% 15.6% 118 bps 561 bps Pretax segment operating income** $807 $664 $396 22% 104% Pretax segment operating margin** 14.3% 12.7% 7.4% 162 bps 694 bps Net income, excluding charges & credits** $431 $299 $69 44% 525% Diluted EPS, excluding charges & credits** $0.30 $0.21 $0.05 43% 500% Revenue by Geography International $4,511 $4,211 $4,224 7% 7% North America* 1,083 972 1,097 11% -1% Other 40 40 35 n/m n/m $5,634 $5,223 $5,356 8% 5% *Schlumberger di
Wyss Center Partners With Artiria Medical to Accelerate a Novel Therapy for Cerebral Vasospasm23.7.2021 11:59:00 CEST | Press release
The Wyss Center and Artiria Medical today announced a new partnership to accelerate the translation of a novel technology that has the potential to reduce deaths and improve quality of life for stroke patients. Artiria Medical, an early-stage medical device company focused on disruptive neurovascular products, has been developing the technology and is now joining forces with the Wyss Center, a non-profit organization dedicated to bringing state-of-the-art therapies to the patient. The team has received support from the Swiss Innovation Agency, Innosuisse, to test and validate the efficacy of the therapy preclinically, in preparation for human clinical studies. Stroke is the third leading cause of disability worldwide with more than 80 million people living with long-term impairments as a result. Some strokes result in bleeding in the brain. Such hemorrhagic strokes can lead to severe cerebral vasospasm - an uncontrolled contraction of brain arteries - in the days that follow, depriving